Prevalence: Over 32.5 million US adults affected (roughly 1 in 7 adults)
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
Glucosamine sulfate (1,500mg/day) and chondroitin (1,200mg/day) are the most studied supplements for osteoarthritis, with the GAIT trial and European guidelines supporting their use for moderate-to-severe knee OA pain.
Osteoarthritis (OA) is the most common form of arthritis, affecting over 32.5 million US adults. It involves progressive degradation of joint cartilage, leading to pain, stiffness, and reduced mobility. Several supplements have demonstrated meaningful benefits for joint pain and function in large-scale clinical trials.
| # | Supplement | Typical Dose | Evidence |
|---|---|---|---|
| 1 | Glucosamine Sulfate | 1,500mg daily | Strong |
| 2 | Chondroitin Sulfate | 800-1,200mg daily | Moderate |
| 3 | Undenatured Type II Collagen (UC-II) | 40mg daily | Moderate |
| 4 | Boswellia Serrata | 100-250mg daily (AKBA-enriched) | Moderate |
| 5 | Omega-3 Fatty Acids | 2-4g EPA+DHA daily | Moderate |
Our recommendations are based on published research, not commission rates. Some links below are affiliate links — we may earn a commission at no extra cost to you. How we evaluate products
Nordic Naturals Ultimate Omega
Nordic Naturals
The evidence is mixed but leans positive for specific forms. Pharmaceutical-grade glucosamine sulfate (not hydrochloride) at 1,500mg/day showed significant benefits in the GUIDE trial and long-term European studies. The NIH-funded GAIT trial found the glucosamine-chondroitin combination was effective for moderate-to-severe knee OA pain. Results typically take 8-12 weeks to become apparent.
For osteoarthritis-related joint pain, UC-II collagen (40mg/day) and glucosamine sulfate (1,500mg/day) have the strongest evidence. A head-to-head trial found UC-II more effective than glucosamine+chondroitin combined. Boswellia serrata (AKBA-enriched, 100-250mg/day) offers faster pain relief, often within 7 days, and works through anti-inflammatory pathways.
Most clinical trials show glucosamine sulfate requires 8-12 weeks of consistent daily use (1,500mg) before meaningful improvements in pain and function are observed. Some patients report gradual improvements as early as 4 weeks. Unlike NSAIDs, glucosamine works by supporting cartilage structure rather than simply blocking pain signals.
Supplements cannot reverse existing cartilage damage, but some may slow progression. A 3-year RCT found glucosamine sulfate (1,500mg/day) reduced joint space narrowing compared to placebo, suggesting a disease-modifying effect. UC-II collagen and boswellia may help preserve remaining cartilage by modulating immune responses and reducing inflammatory enzymes.